Skip to content
Clinical Trials – home
Research siteResponsive

Revita Kft.

Hungary Margit Korut 50-52 Fszt. 9, Kerulet, 1027 Budapest, Hungary

  • 3 trials recruiting
  • Psoriatic arthropathy · Rheumatoid arthritis · Sjogren's syndrome
  • Adult patients

About Specializations

Revita Kft. in Budapest, Hungary specialises in clinical trials of conditions such as Psoriatic arthropathy, Rheumatoid arthritis, Sjogren's syndrome, Axial spondyloarthritis, and other specialisations. This site conducts important research.

Main research areas of the site

Psoriatic Arthritis

The medical center is at the forefront of research in psoriatic arthritis, focusing on innovative treatments that enhance patient outcomes. The center's studies aim to improve the efficacy and safety of new therapeutic agents.

  • Bimekizumab vs. Risankizumab
  • Deucravacitinib Efficacy

These studies contribute significantly to understanding the comparative effectiveness of novel biologics in managing psoriatic arthritis, offering insights into personalized treatment approaches.

Rheumatoid Arthritis

Our institution is renowned for its comprehensive research in rheumatoid arthritis, exploring a wide array of therapeutic strategies to manage this chronic condition effectively.

  • LY3871801 Efficacy
  • Baricitinib vs. TNF Inhibitors
  • Filgotinib Long-term Safety
  • Abatacept Biosimilar Comparison
  • MB04 vs. Enbrel®

Through these studies, the center is advancing the understanding of rheumatoid arthritis treatment, focusing on both efficacy and safety to improve patient quality of life.

Knee Osteoarthritis

The center is actively engaged in research on knee osteoarthritis, aiming to develop effective pain management strategies and improve functional outcomes for patients.

  • DFV890 Efficacy

By investigating new therapeutic options, the center is contributing to the development of more effective treatments for knee osteoarthritis, addressing a significant need in musculoskeletal health.

Polymyalgia Rheumatica

Research at the center includes studies on polymyalgia rheumatica, focusing on the long-term safety and tolerability of emerging treatments.

  • Secukinumab Long-term Safety

These efforts are crucial in enhancing the understanding of treatment safety profiles, ultimately improving therapeutic strategies for polymyalgia rheumatica.

Autoimmune Diseases

The center is pioneering research in autoimmune diseases, with a focus on pharmacokinetic studies to optimize treatment delivery and efficacy.

  • Ianalumab Pharmacokinetics

By exploring the pharmacokinetics of novel therapies, the center is enhancing the precision of treatment regimens for conditions like systemic lupus erythematosus and Sjögren’s disease.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Margit Korut 50-52 Fszt. 9, Kerulet1027 BudapestHungary
Recruiting now
3 trials
Conditions studied
7

More sites in BudapestHungary

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

26 clinical trials

Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:IMEROPRUBART
  • Sponsor:Immunovant Sciences GmbH
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Lutikizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Jnj-77242113
  • Sponsor:Janssen - Cilag International
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Tocilizumab
  • Sponsor:Dr Reddy's Laboratories Limited
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Etanercept
  • Sponsor:Mabxience Research S.L.

Rheumatoid arthritis

Not yet recruiting
Registered drug
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Eli Lilly & Co.

Rheumatoid arthritis

Not recruiting
Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:IMEROPRUBART
  • Sponsor:Immunovant Sciences GmbH
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Risankizumab
  • Sponsor:MoonLake Immunotherapeutics AG
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Sonelokimab
  • Sponsor:MoonLake Immunotherapeutics AG
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Dr Reddy's Laboratories Limited

Psoriatic arthropathy

Not recruiting
Investigational
Countries:HungaryHungary
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.